EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evolution of Non-alcoholic Fatty Liver Disease to Liver Cancer: Insights from Genome-wide Association Studies

Sathish Kumar Mungamuri, Yogendra Kumar Gupta, Padaki Nagaraja Rao, Bagepally Ravishankar

Gene Expression · 2023

DOI: 10.14218/ge.2022.00014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene Expression, 2023. Verfasst von Sathish Kumar Mungamuri und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease, affecting a quarter of the world’s population. The spectrum of NAFLD ranges from simple steatosis, non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and ultimately to hepatocellular carcinoma (HCC). Multiple factors are involved in the pathogenesis and progression of NAFLD, wherein genetic, epigenetic, environmental, gut-microbiome, and dietary factors play a substantial role. Robust genome-wide association studies (GWAS) have recently identified several genetic alterations contributing to NAFLD progression to liver cancer. This review describes the most critical genetic variations identified in various genes that modulate NAFLD pathogenesis. As expected, NAFLD shows gene variations that regulate or influence hepatocyte lipid metabolism. In addition to polymorphisms in genes that regulate insulin signaling, fibrosis, inflammation, and oxidative stress, cytokine/chemokine-expressing genes also participate in NAFLD pathogenesis. GWAS helped us distinguish genetic polymorphisms that modulate steatosis, fibrosis, or both in NAFLD patients. Identifying genetic factors predisposing an individual to NAFLD helps stratify people at high risk and aids in imparting preventive strategies early in life. Such studies should also help in adopting prevention strategies and targeted treatment regimes.

Zitieren

APA

Mungamuri, S. K., Gupta, Y. K., Rao, P. N., & Ravishankar, B. (2023). Evolution of Non-alcoholic Fatty Liver Disease to Liver Cancer: Insights from Genome-wide Association Studies. Gene Expression. https://doi.org/10.14218/ge.2022.00014

Vancouver

Mungamuri SK, Gupta YK, Rao PN, Ravishankar B. Evolution of Non-alcoholic Fatty Liver Disease to Liver Cancer: Insights from Genome-wide Association Studies. Gene Expression. 2023. doi:10.14218/ge.2022.00014

BibTeX
@article{Mungamuri2023,
  author = {Mungamuri, Sathish Kumar and Gupta, Yogendra Kumar and Rao, Padaki Nagaraja and Ravishankar, Bagepally},
  title = {Evolution of Non-alcoholic Fatty Liver Disease to Liver Cancer: Insights from Genome-wide Association Studies},
  journal = {Gene Expression},
  year = {2023},
  doi = {10.14218/ge.2022.00014}
}
Kostenlos starten →